CoChat

The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Women with polycystic ovary syndrome (PCOS) have reproductive and metabolic abnormalities that result in an increased risk of infertility, diabetes and cardiovascular disease. The large intestine contains a complex community of microorganisms (the gut microbiome) that is dysregulated in humans with obesity and type 2 diabetes. Using a letrozole-induced PCOS mouse model, we demonstrated significant diet-independent changes in the gut microbial community, suggesting that gut microbiome dysbiosis may also occur in PCOS women. Letrozole treatment was associated with a time-dependent shift in the gut microbiome and a substantial reduction in overall species and phylogenetic richness. Letrozole treatment also correlated with significant changes in the abundance of specific Bacteroidetes and Firmicutes previously implicated in other mouse models of metabolic disease in a time-dependent manner. Our results suggest that the hyperandrogenemia observed in PCOS may significantly alter the gut microbiome independently of diet.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0146509

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Letrozole treatment of 4-week-old female mice resulted in both reproductive and metabolic hallmarks of PCOS. Five weeks of letrozole treatment resulted in increased serum testosterone (A), acyclicity (B), polycystic ovaries (C), increased body weight (D), increased fat mass (E), increased parametrial fat pad relative to body weight (F), and an impaired glucose tolerance test with elevated basal glucose levels and significant delays in glucose clearance after intraperitoneal injection previously published in [35] (G); n = 10 placebo (P) and letrozole (LET). * p<0.05 Student’s t-test. CL, corpus luteum.
Fig 1 Letrozole treatment of 4-week-old female mice resulted in both reproductive and metabolic hallmarks of PCOS. Five weeks of letrozole treatment resulted in increased serum testosterone (A), acyclicity (B), polycystic ovaries (C), increased body weight (D), increased fat mass (E), increased parametrial fat pad relative to body weight (F), and an impaired glucose tolerance test with elevated basal glucose levels and significant delays in glucose clearance after intraperitoneal injection previously published in [35] (G); n = 10 placebo (P) and letrozole (LET). * p<0.05 Student’s t-test. CL, corpus luteum.CC BY · PubMed Central
Fig 2 Letrozole treatment blocks the increase in species abundance and phylogenetic diversity observed over time. Chao1 species (OTU) richness estimates per sample at each collection time for placebo (A) and letrozole-treated mice (B). Faith’s phylogenetic diversity estimate per sample at each collection time for placebo (C) and letrozole-treated mice (D). Results of Pearson’s correlation shown in box inset along with line of best fit. Comparison of Chao1 and Faith’s PD after 5 weeks of placebo or letrozole treatment (ANOVA; * p<0.05) (E), Scatter plot and trend line showing relationship between testosterone levels and change in Chao1 diversity within individuals (time 5 minus time 0) (F). Result of Spearman’s correlation shown in box inset.
Fig 2 Letrozole treatment blocks the increase in species abundance and phylogenetic diversity observed over time. Chao1 species (OTU) richness estimates per sample at each collection time for placebo (A) and letrozole-treated mice (B). Faith’s phylogenetic diversity estimate per sample at each collection time for placebo (C) and letrozole-treated mice (D). Results of Pearson’s correlation shown in box inset along with line of best fit. Comparison of Chao1 and Faith’s PD after 5 weeks of placebo or letrozole treatment (ANOVA; * p<0.05) (E), Scatter plot and trend line showing relationship between testosterone levels and change in Chao1 diversity within individuals (time 5 minus time 0) (F). Result of Spearman’s correlation shown in box inset.CC BY · PubMed Central
Fig 3 Letrozole treatment results in a significant shift in gut microbiome beta diversity. Principle Coordinates Analysis based on unweighted (A) and weighted (B) UniFrac distances. Comparison of samples collected post-treatment from placebo and letrozole treated mice.
Fig 3 Letrozole treatment results in a significant shift in gut microbiome beta diversity. Principle Coordinates Analysis based on unweighted (A) and weighted (B) UniFrac distances. Comparison of samples collected post-treatment from placebo and letrozole treated mice.CC BY · PubMed Central
Fig 4 Letrozole results in a shift in beta diversity after one week of treatment. Principle Coordinates Analysis based on unweighted UniFrac distances. Comparison of samples from placebo-treated mice colored by collection time, week 0–5 (A). Comparison of samples from letrozole-treated mice colored by collection time, week 0–5 (B). Box and whisker plots showing mean and variance of average pair-wise unweighted UniFrac distances between collection time (week) 0 and all other collection time points in the study for placebo (C) and letrozole-treated mice (D). Bars above the graphs indicate when mean differences between time points were significantly different from mean UniFrac distances within all time points, * p<0.05, ** p<0.01, *** p<0.001.
Fig 4 Letrozole results in a shift in beta diversity after one week of treatment. Principle Coordinates Analysis based on unweighted UniFrac distances. Comparison of samples from placebo-treated mice colored by collection time, week 0–5 (A). Comparison of samples from letrozole-treated mice colored by collection time, week 0–5 (B). Box and whisker plots showing mean and variance of average pair-wise unweighted UniFrac distances between collection time (week) 0 and all other collection time points in the study for placebo (C) and letrozole-treated mice (D). Bars above the graphs indicate when mean differences between time points were significantly different from mean UniFrac distances within all time points, * p<0.05, ** p<0.01, *** p<0.001.CC BY · PubMed Central
Fig 5 Letrozole treatment resulted in a decrease in Bacteroidales and increase in Clostridiales. Relative abundance of specific bacteria grouped by order in placebo and letrozole treated mice at the end of the study (week 5).
Fig 5 Letrozole treatment resulted in a decrease in Bacteroidales and increase in Clostridiales. Relative abundance of specific bacteria grouped by order in placebo and letrozole treated mice at the end of the study (week 5).CC BY · PubMed Central
Fig 6 Time-dependent response to letrozole treatment varies among bacterial species. Box and whisker plots showing average ranked abundances of 6 OTUs at each collection time for placebo and letrozole treated mice, as indicated.
Fig 6 Time-dependent response to letrozole treatment varies among bacterial species. Box and whisker plots showing average ranked abundances of 6 OTUs at each collection time for placebo and letrozole treated mice, as indicated.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 55 references

Cited by

See all 205

Metadata

Authors
Kelley, S. T., Skarra, D. V., Rivera, A. J., & Thackray, V. G.
Affiliations
  • San Diego State University (US)
  • University of California San Diego (US)
Corresponding author
Thackray, Varykina G.
Venue
PLOS ONE
Published
2016-01-05
Volume
11
Issue
1
Pages
e0146509
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2225512866
Cited by
205
References
55
Citations by year
2026: 18 · 2025: 26 · 2024: 25 · 2023: 31 · 2022: 18 · 2021: 32 · 2020: 20 · 2019: 14 · 2018: 13 · 2017: 5 · 2016: 2
FWCI
5.89
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
  • University of Virginia (U54-HD28934)
  • University of California, San Diego
  • National Institute of General Medical Sciences (GM-068524, K12GM068524)
  • National Institute of Child Health and Human Development (U54-HD28934, HD012303)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD012303, R01HD082567, F32HD074414, U54HD012303, U54HD028934, P50HD028934, R01HD067448, T32HD007203, U54-HD-28934)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
polycystic ovary syndrome, gut microbiota, dysbiosis, letrozole, hyperandrogenemia, Bacteroidetes, Firmicutes, species richness, mouse model, infertility, metabolic disorders
MeSH terms
Gastrointestinal Microbiome, Letrozole, Animals, Diet, Disease Models, Animal, Female, Nitriles, Polycystic Ovary Syndrome, Triazoles, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.1371/journal.pone.0146509
The paper
Kelley, S. T., Skarra, D. V., Rivera, A. J., & Thackray, V. G. (2016). The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome. PLOS ONE. https://doi.org/10.1371/journal.pone.0146509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.